Drugs and tight junctions: adverse effects and opportunities for new therapeutic approaches

J Pediatr Gastroenterol Nutr. 2012 Apr;54(4):444-5. doi: 10.1097/MPG.0b013e3182472372.
No abstract available

Publication types

  • Comment

MeSH terms

  • Animals
  • Humans
  • MAP Kinase Signaling System*
  • Male
  • Methotrexate / pharmacology*
  • NF-kappa B / metabolism*
  • Tight Junctions / drug effects*

Substances

  • NF-kappa B
  • Methotrexate